CIPLANSECipla Limited· PharmaceuticalsLowNeutral
Announced Wed, 16 Jul · 22:29 IST

Cipla Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 16, 2025

Board & Shareholder Meetings View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Cipla Limited held its 89th Annual General Meeting on July 16, 2025, via video conferencing, and all six resolutions on the agenda were passed with overwhelming shareholder support. The resolutions covered adoption of audited standalone and consolidated financial statements for FY25, declaration of a dividend on equity shares, re-appointment of Mr. Umang Vohra (Managing Director) as a director liable to retire by rotation, ratification of the Cost Auditor's remuneration for FY26, and appointment of the Secretarial Auditor. Of the 562,766 shareholders on record date, 2,060 cast valid votes representing roughly 64.12 crore shares. Each resolution received over 99.77% votes in favour, with the dividend and auditor-related resolutions exceeding 99.999% support.

Likely market impact

This is a routine post-AGM regulatory disclosure confirming shareholder approval on standard items. The key shareholder-relevant item is the dividend declaration; the broad-based approval across all resolutions, including the re-appointment of the Managing Director, signals strong institutional and retail confidence and is unlikely to trigger any meaningful stock price reaction on its own.